NO20004980L - Particulate articles of active ingredients for pulmonary use - Google Patents
Particulate articles of active ingredients for pulmonary useInfo
- Publication number
- NO20004980L NO20004980L NO20004980A NO20004980A NO20004980L NO 20004980 L NO20004980 L NO 20004980L NO 20004980 A NO20004980 A NO 20004980A NO 20004980 A NO20004980 A NO 20004980A NO 20004980 L NO20004980 L NO 20004980L
- Authority
- NO
- Norway
- Prior art keywords
- active ingredients
- particulate
- pulmonary use
- particulate articles
- pulmonary
- Prior art date
Links
- 230000002685 pulmonary effect Effects 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 229920001503 Glucan Polymers 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
Abstract
Oppfinnelsen angår tilveiebringelse av en partikulær virkestoffbærer og dens farmasøytiske sammensetning med depotvirkning for pulmonal applikasjon. Den tønformulerbare biokompatible, partikulære virkestoffbæreren fremstilles helt eller til dels av lineære vannuoppløselige polysakkarider, fortrinnsvis poly(l,4-a-D-glukan), med homogen enhetlig størrelse fra fortrinnsvis biotransformatorisk fremstilling med evnen til å kluster- og/eller agglomeratdannelse. De derav resulterende fordeler benyttes fortrinnsvis i rammen av den tørre pulverinhaleringen.The invention relates to the provision of a particulate active substance and its pharmaceutical composition with depot effect for pulmonary application. The barrel-formulated biocompatible particulate carrier is prepared wholly or in part by linear water-insoluble polysaccharides, preferably poly (1,4-a-D-glucan), of homogeneous uniform size, preferably from biotransformational preparation with the ability to cluster and / or agglomerate formation. The resulting advantages are preferably used in the frame of the dry powder inhalation.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19816085 | 1998-04-09 | ||
| PCT/EP1999/002385 WO1999052506A1 (en) | 1998-04-09 | 1999-04-08 | Particulate active agent support for pulmonary application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004980D0 NO20004980D0 (en) | 2000-10-03 |
| NO20004980L true NO20004980L (en) | 2000-12-08 |
Family
ID=7864224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004980A NO20004980L (en) | 1998-04-09 | 2000-10-03 | Particulate articles of active ingredients for pulmonary use |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1069889B1 (en) |
| JP (1) | JP2002511399A (en) |
| KR (1) | KR20010034755A (en) |
| CN (1) | CN1423553A (en) |
| AT (1) | ATE270097T1 (en) |
| AU (1) | AU3421099A (en) |
| CA (1) | CA2340340A1 (en) |
| DE (1) | DE59909854D1 (en) |
| HU (1) | HUP0101912A2 (en) |
| NO (1) | NO20004980L (en) |
| PL (1) | PL343342A1 (en) |
| WO (1) | WO1999052506A1 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19847593A1 (en) * | 1998-10-15 | 2000-04-20 | Aventis Res & Tech Gmbh & Co | Parenteral drug administration composition with depot and controlled release comprises active agent and water soluble polysaccharide microparticles as carrier |
| ES2395096T3 (en) | 1999-06-29 | 2013-02-08 | Mannkind Corporation | Purification and stabilization of pharmaceutical agents based on peptides and proteins |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| JP4681231B2 (en) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | Inhaler |
| US20080090753A1 (en) | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
| ATE486064T1 (en) | 2004-08-20 | 2010-11-15 | Mannkind Corp | CATALYSIS OF DIKETOPIPERAZINE SYNTHESIS |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diketopiperazine salts for drug delivery |
| MX373000B (en) | 2005-09-14 | 2020-05-21 | Mannkind Corp | METHOD FOR FORMULATING A DRUG BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS TOWARDS THE SURFACES OF CRYSTALLINE MICROPARTICLES. |
| US8084420B2 (en) | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| CN104383546B (en) * | 2006-02-22 | 2021-03-02 | 曼金德公司 | Method for improving the pharmaceutical properties of microparticles comprising diketopiperazines and an active agent |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI494123B (en) | 2008-08-11 | 2015-08-01 | Mannkind Corp | Ultra-fast use of insulin |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| SG10201403147SA (en) | 2009-06-12 | 2014-10-30 | Mannkind Corp | Diketopiperazine microparticles with defined isomer contents |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| JP5784622B2 (en) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | Apparatus and method for simulating inhalation activity |
| RU2531455C2 (en) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Systems and methods for dry powder drugs delivery |
| MX353285B (en) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Blister package for pharmaceutical cartridges. |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| BR112015010601B1 (en) * | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION |
| BR112015023168B1 (en) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | COMPOSITION OF 3,6-BIS(N-FUMARYL-4-AMINOBUTYL)-2,5-CRYSTALLINE DICETOPIPERAZINE, METHOD OF PRODUCTION OF 3,6-BIS(N-FUMARYL-4-AMINOBUTYL)-2,5-DICETOPIPERAZINE PARTICLES AND USE OF A CRYSTALLINE DICETOPIPERAZINE COMPOSITION |
| BR122019026637B1 (en) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | PHARMACEUTICAL DRY POWDER FORMULATIONS AND METHOD FOR MANUFACTURING A DRY POWDER FORMULATION |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| WO2018222581A1 (en) * | 2017-05-29 | 2018-12-06 | Resinnate Therapeutics Llc | Methods and formulations for administering beta glucan |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB937303A (en) * | 1959-01-02 | 1963-09-18 | Benger Lab Ltd | Improvements in and relating to the application of drugs in finely divided condition |
| US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| GB9606188D0 (en) * | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
| DE19737481A1 (en) * | 1997-08-28 | 1999-03-04 | Hoechst Ag | Microparticles containing spherical linear polysaccharides |
-
1999
- 1999-04-08 PL PL99343342A patent/PL343342A1/en unknown
- 1999-04-08 EP EP99915750A patent/EP1069889B1/en not_active Expired - Lifetime
- 1999-04-08 KR KR1020007011142A patent/KR20010034755A/en not_active Withdrawn
- 1999-04-08 AT AT99915750T patent/ATE270097T1/en not_active IP Right Cessation
- 1999-04-08 CN CN99806153A patent/CN1423553A/en active Pending
- 1999-04-08 CA CA002340340A patent/CA2340340A1/en not_active Abandoned
- 1999-04-08 WO PCT/EP1999/002385 patent/WO1999052506A1/en not_active Ceased
- 1999-04-08 DE DE59909854T patent/DE59909854D1/en not_active Expired - Lifetime
- 1999-04-08 HU HU0101912A patent/HUP0101912A2/en unknown
- 1999-04-08 AU AU34210/99A patent/AU3421099A/en not_active Abandoned
- 1999-04-08 JP JP2000543116A patent/JP2002511399A/en active Pending
-
2000
- 2000-10-03 NO NO20004980A patent/NO20004980L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0101912A2 (en) | 2001-10-28 |
| AU3421099A (en) | 1999-11-01 |
| EP1069889A1 (en) | 2001-01-24 |
| CA2340340A1 (en) | 1999-10-21 |
| ATE270097T1 (en) | 2004-07-15 |
| KR20010034755A (en) | 2001-04-25 |
| JP2002511399A (en) | 2002-04-16 |
| NO20004980D0 (en) | 2000-10-03 |
| DE59909854D1 (en) | 2004-08-05 |
| EP1069889B1 (en) | 2004-06-30 |
| PL343342A1 (en) | 2001-08-13 |
| CN1423553A (en) | 2003-06-11 |
| WO1999052506B1 (en) | 1999-11-25 |
| WO1999052506A1 (en) | 1999-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004980D0 (en) | Particulate active carrier for pulmonary use | |
| CN100543427C (en) | calcium carbonate particles | |
| RU2008112146A (en) | COMPOSITIONS AND METHODS FOR PRODUCING MEDICINAL PRODUCTS Slightly Soluble in Water with Increased Stability | |
| GB1484781A (en) | Compositions for dental treatment | |
| YU24201A (en) | Aerosolizable dry powder particles resistant to hygroscopic growth | |
| ATE73472T1 (en) | PROCESS FOR MANUFACTURE OF A CONTROLLED DELIVERY SYSTEM FOR CALCIUM. | |
| DK486189D0 (en) | PSYLLIUM FRESH CALLS AND AGENTS COMPREHENSIVE TOGETHER | |
| GB2223405A (en) | Effervescent iron composition | |
| Bowyer | Osteophagia and antler breakage among Roosevelt elk. | |
| US2949401A (en) | Buccal tablet containing vitamin a | |
| KR100740370B1 (en) | Composition comprising ascorbic acid and pectin | |
| CN110916155A (en) | Local chicken essence and preparation method thereof | |
| WO2005084703A1 (en) | Sustained-release composition for oral cavity | |
| JPH0651628B2 (en) | Nutritional composition | |
| CN113081893A (en) | Oral bacteriostatic composition, preparation method and application thereof | |
| KR101861658B1 (en) | Gel composition comprising mineral | |
| JPWO2005092124A1 (en) | Method for producing health food containing dietary fiber | |
| CN114948765B (en) | Mouthwash and preparation method thereof | |
| BRPI0212195B1 (en) | COMPOSITIONS CONTAINING PECTIN AND ASCORBIC ACID | |
| RU97114578A (en) | BIOLOGICALLY ACTIVE CORRIDA FOOD ADDITIVES | |
| JPS62228272A (en) | Stable peroxidase formulation | |
| JPH06247860A (en) | Iron absorption promoter comprising decomposition product of guar gum with enzyme as active ingredient | |
| JP7429076B1 (en) | Powder containing lactic acid bacteria, disinfectant, oral care agent | |
| JP2602712B2 (en) | Heme iron-containing composition | |
| CN103877050B (en) | Vitamin c soluble tablet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |